813 related articles for article (PubMed ID: 19683480)
1. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
3. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
Turtoi A; Mazzucchelli GD; De Pauw E
Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
[TBL] [Abstract][Full Text] [Related]
4. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
6. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
7. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
[TBL] [Abstract][Full Text] [Related]
8. Development of an integrated approach for evaluation of 2-D gel image analysis: impact of multiple proteins in single spots on comparative proteomics in conventional 2-D gel/MALDI workflow.
Yang Y; Thannhauser TW; Li L; Zhang S
Electrophoresis; 2007 Jun; 28(12):2080-94. PubMed ID: 17486657
[TBL] [Abstract][Full Text] [Related]
9. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
Merrell K; Thulin CD; Esplin MS; Graves SW
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
[TBL] [Abstract][Full Text] [Related]
10. SuperHirn - a novel tool for high resolution LC-MS-based peptide/protein profiling.
Mueller LN; Rinner O; Schmidt A; Letarte S; Bodenmiller B; Brusniak MY; Vitek O; Aebersold R; Müller M
Proteomics; 2007 Oct; 7(19):3470-80. PubMed ID: 17726677
[TBL] [Abstract][Full Text] [Related]
11. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
12. Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometry.
Nanni P; Mezzanotte L; Roda G; Caponi A; Levander F; James P; Roda A
J Proteomics; 2009 Jul; 72(5):865-73. PubMed ID: 19168159
[TBL] [Abstract][Full Text] [Related]
13. ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics.
Mann B; Madera M; Sheng Q; Tang H; Mechref Y; Novotny MV
Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3823-34. PubMed ID: 18985620
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
[TBL] [Abstract][Full Text] [Related]
15. Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments.
Wong JW; Sullivan MJ; Cagney G
Brief Bioinform; 2008 Mar; 9(2):156-65. PubMed ID: 17905794
[TBL] [Abstract][Full Text] [Related]
16. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome.
Cutillas PR; Norden AG; Cramer R; Burlingame AL; Unwin RJ
Clin Sci (Lond); 2003 May; 104(5):483-90. PubMed ID: 12529166
[TBL] [Abstract][Full Text] [Related]
17. An iterative strategy for precursor ion selection for LC-MS/MS based shotgun proteomics.
Zerck A; Nordhoff E; Resemann A; Mirgorodskaya E; Suckau D; Reinert K; Lehrach H; Gobom J
J Proteome Res; 2009 Jul; 8(7):3239-51. PubMed ID: 19402737
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.
Leng J; Zhu D; Wu D; Zhu T; Zhao N; Guo Y
Rapid Commun Mass Spectrom; 2012 Nov; 26(21):2555-62. PubMed ID: 23008073
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric identification of serum peptides employing derivatized poly(glycidyl methacrylate/divinyl benzene) particles and mu-HPLC.
Rainer M; Najam-ul-Haq M; Bakry R; Huck CW; Bonn GK
J Proteome Res; 2007 Jan; 6(1):382-6. PubMed ID: 17203982
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of potential bortezomib response markers in mutliple myeloma patients.
Hsieh FY; Tengstrand E; Pekol TM; Guerciolini R; Miwa G
J Pharm Biomed Anal; 2009 Jan; 49(1):115-22. PubMed ID: 19062221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
